Penas, Susana http://orcid.org/0000-0001-7696-1957
Araújo, Teresa
Mendonça, Ana Maria
Faria, Simão
Silva, Jorge
Campilho, Aurélio
Martins, Maria Lurdes
Sousa, Vânia
Rocha-Sousa, Amândio
Carneiro, Ângela
Falcão-Reis, Fernando
Article History
Received: 10 March 2022
Revised: 22 June 2022
Accepted: 30 June 2022
First Online: 15 July 2022
Declarations
:
: A written consent was obtained for all the participants in this study.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee For Health From Centro Hospitalar Universitário de São João (project 52/2016), and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: S.P.: participation in advisory boards for Alimera, Bayer, Novartis, Roche. A.C.: participation in advisory boards for Allergan, Alimera, Bayer, Novartis, and Roche. All the other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.